Citation Impact
Citing Papers
Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions
2005 Standout
Defining acute flares in knee osteoarthritis: a systematic review
2018
Evaluating the Feasibility of ChatGPT in Healthcare: An Analysis of Multiple Clinical and Research Scenarios
2023 Standout
The Pathogenesis of Lupus Nephritis
2013
An Expanded View of Complex Traits: From Polygenic to Omnigenic
2017 Standout
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
2012 Standout
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Chemokines and leukocyte traffic
1998 StandoutNature
Reaction of MDCK cells to crystals of monosodium urate monohydrate and uric acid
1990
Mechanism and medical implications of mammalian autophagy
2018 Standout
Integrating Autoimmune Risk Loci with Gene-Expression Data Identifies Specific Pathogenic Immune Cell Subsets
2011
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
2020 Standout
Systemic lupus erythematosus
2016
OARSI guidelines for the non-surgical management of knee osteoarthritis
2014 Standout
Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: A randomized controlled trial
2004
Encoded libraries of chemically modified peptides
2015 StandoutNobel
The Human Transcription Factors
2018 Standout
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
2011 StandoutNobel
The JAK/STAT signaling pathway: from bench to clinic
2021 Standout
Systemic Lupus Erythematosus
2011 Standout
What is new in the management of rapidly progressive glomerulonephritis?
2015
A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader
2017
Adherence to treatment in systemic lupus erythematosus patients
2013
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
2011
Emerging trends in the pharmacotherapy of chronic pain
2003
Need for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: Case study of cyclooxygenase 2-selective inhibitors for the treatment of osteoarthritis
2005
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials
2007
Management of Patients With Ulcer Bleeding
2012 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Rheumatoid arthritis
2010 Standout
Non‐medical use of prescription stimulants among US college students: prevalence and correlates from a national survey
2004 Standout
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
2017 Standout
Systemic lupus erythematosus
2014
Deciphering the role of NETs and networks in SLE
2012
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
Clinical targeting of the TNF and TNFR superfamilies
2013
Points of control in inflammation
2002 StandoutNature
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Autophagy: controlling cell fate in rheumatic diseases
2016
Belimumab: Review of Use in Systemic Lupus Erythematosus
2012
Osteoarthritis
2019 Standout
Gastrointestinal Safety of Cyclooxygenase-2 Inhibitors: A Cochrane Collaboration Systematic Review
2007
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Therapeutic Targeting of B Cells for Rheumatic Autoimmune Diseases
2011
epic3: National Evidence-Based Guidelines for Preventing Healthcare-Associated Infections in NHS Hospitals in England
2013 Standout
Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines.
1994 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
2015 Standout
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus
2022
Chemokines
1997 Standout
Drugs derived from phage display
2013
Meta-analysis of Cyclooxygenase-2 Inhibitors and Their Effects on Blood Pressure
2005
Strain-Specific Manifestation of Lupus-like Systemic Autoimmunity Caused by Zap70 Mutation
2019 StandoutNobel
Chemotactic Factor Inactivation by the Myeloperoxidase-Hydrogen Peroxide-Halide System
1979
Prolonged reduction in polymorphonuclear adhesion following oral colchicine.
1981
Molecular and Cellular Mechanisms of Leukocyte Chemotaxis
1981 Science
The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity states
1982 StandoutNobel
Guanine nucleotides modulate the binding affinity of the oligopeptide chemoattractant receptor on human polymorphonuclear leukocytes.
1983 StandoutNobel
Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin
1983 StandoutNobel
Is Cytosolic Ionized Calcium Regulating Neutrophil Activation?
1983 StandoutScienceNobel
Tubulointerstitial Changes as a Major Determinant in the Progression of Renal Damage
1992 Standout
Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic
2004
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Atherosclerosis in Systemic Lupus Erythematosus
2013
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
2017
Platelet factor 4 is chemotactic for neutrophils and monocytes.
1981
Attenuation of monosodium urate crystal-induced arthritis in rabbits by a neutralizing antibody against interleukin-8
1997
The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
2014 Standout
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
2008
2020 International Society of Hypertension Global Hypertension Practice Guidelines
2020 Standout
The Pathogenesis of Atherosclerosis — An Update
1986 Standout
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Phage display-derived human antibodies in clinical development and therapy
2016
Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
2009
Works of A Gallacher being referenced
Late‐breaking abstracts: American College of Rheumatology 2009 Annual Scientific Meeting
2009
Efficacy and Tolerability Profile of Etoricoxib in Patients with Osteoarthritis: A Randomized, Double-blind, Placebo and Active-comparator Controlled 12-Week Efficacy Trial
2002
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
2011
Studies on crystal-induced chemotactic factor. II. Role of phagocytosis.
1975
Urate crystal-induced chemotactic factor: isolation and partial characterization.
1976
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosus
2012